As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at one-year follow-up Additional data demonstrated improved preservation of kidney. | June 5, 2023
Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapyMALVERN, Pa., May 18, 2023 Galera Therapeutics, Inc. , a clinical-stage. | June 11, 2023
Community Calendar - Chesterton Tribune chestertontribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chestertontribune.com Daily Mail and Mail on Sunday newspapers.